322 related articles for article (PubMed ID: 35727341)
1. Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases.
Abati E; Manini A; Comi GP; Corti S
Cell Mol Life Sci; 2022 Jun; 79(7):374. PubMed ID: 35727341
[TBL] [Abstract][Full Text] [Related]
2. Advances and limitations for the treatment of spinal muscular atrophy.
Day JW; Howell K; Place A; Long K; Rossello J; Kertesz N; Nomikos G
BMC Pediatr; 2022 Nov; 22(1):632. PubMed ID: 36329412
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice.
Sumner CJ; Wee CD; Warsing LC; Choe DW; Ng AS; Lutz C; Wagner KR
Hum Mol Genet; 2009 Sep; 18(17):3145-52. PubMed ID: 19477958
[TBL] [Abstract][Full Text] [Related]
4. Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.
Zhou H; Meng J; Malerba A; Catapano F; Sintusek P; Jarmin S; Feng L; Lu-Nguyen N; Sun L; Mariot V; Dumonceaux J; Morgan JE; Gissen P; Dickson G; Muntoni F
J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):768-782. PubMed ID: 32031328
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy.
Long KK; O'Shea KM; Khairallah RJ; Howell K; Paushkin S; Chen KS; Cote SM; Webster MT; Stains JP; Treece E; Buckler A; Donovan A
Hum Mol Genet; 2019 Apr; 28(7):1076-1089. PubMed ID: 30481286
[TBL] [Abstract][Full Text] [Related]
6. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis.
Holzbaur EL; Howland DS; Weber N; Wallace K; She Y; Kwak S; Tchistiakova LA; Murphy E; Hinson J; Karim R; Tan XY; Kelley P; McGill KC; Williams G; Hobbs C; Doherty P; Zaleska MM; Pangalos MN; Walsh FS
Neurobiol Dis; 2006 Sep; 23(3):697-707. PubMed ID: 16837207
[TBL] [Abstract][Full Text] [Related]
7. Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.
Rindt H; Buckley DM; Vale SM; Krogman M; Rose FF; Garcia ML; Lorson CL
Neuromuscul Disord; 2012 Mar; 22(3):277-85. PubMed ID: 22079083
[TBL] [Abstract][Full Text] [Related]
8. Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade.
Cantara S; Simoncelli G; Ricci C
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732027
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset.
Feng Z; Ling KK; Zhao X; Zhou C; Karp G; Welch EM; Naryshkin N; Ratni H; Chen KS; Metzger F; Paushkin S; Weetall M; Ko CP
Hum Mol Genet; 2016 Mar; 25(5):964-75. PubMed ID: 26758873
[TBL] [Abstract][Full Text] [Related]
10. Carboxyl-terminal modulator protein regulates Akt signaling during skeletal muscle atrophy in vitro and a mouse model of amyotrophic lateral sclerosis.
Wang J; Fry CME; Walker CL
Sci Rep; 2019 Mar; 9(1):3920. PubMed ID: 30850672
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.
Malacarne C; Galbiati M; Giagnorio E; Cavalcante P; Salerno F; Andreetta F; Cagnoli C; Taiana M; Nizzardo M; Corti S; Pensato V; Venerando A; Gellera C; Fenu S; Pareyson D; Masson R; Maggi L; Dalla Bella E; Lauria G; Mantegazza R; Bernasconi P; Poletti A; Bonanno S; Marcuzzo S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073630
[TBL] [Abstract][Full Text] [Related]
13. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.
Marcuzzo S; Zucca I; Mastropietro A; de Rosbo NK; Cavalcante P; Tartari S; Bonanno S; Preite L; Mantegazza R; Bernasconi P
Exp Neurol; 2011 Sep; 231(1):30-7. PubMed ID: 21620832
[TBL] [Abstract][Full Text] [Related]
14. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis.
Morrison BM; Lachey JL; Warsing LC; Ting BL; Pullen AE; Underwood KW; Kumar R; Sako D; Grinberg A; Wong V; Colantuoni E; Seehra JS; Wagner KR
Exp Neurol; 2009 Jun; 217(2):258-68. PubMed ID: 19285073
[TBL] [Abstract][Full Text] [Related]
15. Past, Present, and Future Perspective of Targeting Myostatin and Related Signaling Pathways to Counteract Muscle Atrophy.
Hoogaars WMH; Jaspers RT
Adv Exp Med Biol; 2018; 1088():153-206. PubMed ID: 30390252
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA).
Fayzullina S; Martin LJ
PLoS One; 2014; 9(3):e93329. PubMed ID: 24667816
[TBL] [Abstract][Full Text] [Related]
17. Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy.
Liu M; Hammers DW; Barton ER; Sweeney HL
PLoS One; 2016; 11(11):e0166803. PubMed ID: 27870893
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Safety Assessment and Toxicokinetics of Apitegromab, an Antibody Targeting Proforms of Myostatin for the Treatment of Muscle-Atrophying Disease.
Welsh BT; Cote SM; Meshulam D; Jackson J; Pal A; Lansita J; Kalra A
Int J Toxicol; 2021; 40(4):322-336. PubMed ID: 34255983
[TBL] [Abstract][Full Text] [Related]
19. Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.
Rose FF; Mattis VB; Rindt H; Lorson CL
Hum Mol Genet; 2009 Mar; 18(6):997-1005. PubMed ID: 19074460
[TBL] [Abstract][Full Text] [Related]
20. Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.
Kariya S; Re DB; Jacquier A; Nelson K; Przedborski S; Monani UR
Hum Mol Genet; 2012 Aug; 21(15):3421-34. PubMed ID: 22581780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
